HOXA9 and acute myeloid leukemia: Pharmacological and genetic suppression of G9a has been shown to effectively slow down the proliferation of AML cells and leukemia stem cells (LSCs) in a mouse model due to suppression of HOXA9-dependent transcription [84,85].